168 related articles for article (PubMed ID: 18551103)
1. Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study.
Peer N; Steyn K; Dennison CR; Levitt NS; Nyo MT; Nel JH; Commerford PJ; Fourie JM; Hill MN
Am J Hypertens; 2008 Aug; 21(8):896-902. PubMed ID: 18551103
[TBL] [Abstract][Full Text] [Related]
2. Target-organ damage and cardiovascular complications in hypertensive Nigerian Yoruba adults: a cross-sectional study.
Oladapo OO; Salako L; Sadiq L; Shoyinka K; Adedapo K; Falase AO
Cardiovasc J Afr; 2012 Aug; 23(7):379-84. PubMed ID: 22914995
[TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
[TBL] [Abstract][Full Text] [Related]
4. The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.
Antikainen R; Grodzicki T; Palmer AJ; Beevers DG; Coles EC; Webster J; Bulpitt CJ
J Hum Hypertens; 2003 Mar; 17(3):159-64. PubMed ID: 12624605
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk and comorbid conditions among Black South Africans with hypertension in public and private primary care settings: the HiHi study.
Dennison CR; Peer N; Lombard CJ; Kepe L; Levitt NS; Steyn K; Hill MN
Ethn Dis; 2007; 17(3):477-83. PubMed ID: 17985501
[TBL] [Abstract][Full Text] [Related]
6. Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda.
Nabbaale J; Kibirige D; Ssekasanvu E; Sebatta ES; Kayima J; Lwabi P; Kalyesubula R
BMC Res Notes; 2015 May; 8():198. PubMed ID: 25971452
[TBL] [Abstract][Full Text] [Related]
7. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
[TBL] [Abstract][Full Text] [Related]
9. Mild renal dysfunction and cardiovascular risk in hypertensive patients.
Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Deferrari G; Pontremoli R
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S88-90. PubMed ID: 14684681
[TBL] [Abstract][Full Text] [Related]
10. Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient.
Chapman JN; Mayet J; Chang CL; Foale RA; Thom SA; Poulter NR
Am J Hypertens; 1999 May; 12(5):437-42. PubMed ID: 10342780
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
Okin PM; Wright JT; Nieminen MS; Jern S; Taylor AL; Phillips R; Papademetriou V; Clark LT; Ofili EO; Randall OS; Oikarinen L; Viitasalo M; Toivonen L; Julius S; Dahlöf B; Devereux RB
Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of microalbuminuria and ECG left ventricular hypertrophy in hypertensive patients in private practices in South Africa.
Rayner B; Becker P
Cardiovasc J S Afr; 2006; 17(5):245-9. PubMed ID: 17117229
[TBL] [Abstract][Full Text] [Related]
13. Office and Home Blood Pressures as Determinants of Electrocardiographic Left Ventricular Hypertrophy Among Black Nigerians Compared With White Flemish.
Odili AN; Thijs L; Yang WY; Ogedengbe JO; Nwegbu MM; Jacobs L; Wei FF; Feng YM; Zhang ZY; Kuznetsova T; Nawrot TS; Staessen JA
Am J Hypertens; 2017 Nov; 30(11):1083-1092. PubMed ID: 29059302
[TBL] [Abstract][Full Text] [Related]
14. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
Edison ES; Yano Y; Hoshide S; Kario K
Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional study of prevalence and determinants of uncontrolled hypertension among South African adult residents of Mkhondo municipality.
Masilela C; Pearce B; Ongole JJ; Adeniyi OV; Benjeddou M
BMC Public Health; 2020 Jul; 20(1):1069. PubMed ID: 32631300
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Araoye's criteria with standard electrocardiographic criteria for diagnosis of left ventricular hypertrophy in Nigerian hypertensives.
Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
West Afr J Med; 2006; 25(3):179-85. PubMed ID: 17191415
[TBL] [Abstract][Full Text] [Related]
17. Determinants of hypertension care and control among peri-urban Black South Africans: the HiHi study.
Dennison CR; Peer N; Steyn K; Levitt NS; Hill MN
Ethn Dis; 2007; 17(3):484-91. PubMed ID: 17985502
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
Ulasi II; Arodiwe EB; Ijoma CK
Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in electrocardiographic left ventricular hypertrophy in young and middle-aged employed American men.
Xie X; Liu K; Stamler J; Stamler R
Am J Cardiol; 1994 Mar; 73(8):564-7. PubMed ID: 8147301
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure variability is significantly associated with ECG left ventricular mass in normotensive Africans: the SABPA Study.
Schutte AE; Schutte R; Huisman HW; van Rooyen JM; Fourie CM; Malan NT; Malan L
Hypertens Res; 2011 Oct; 34(10):1127-34. PubMed ID: 21796132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
